Regulatory Updates

The QbD Group regulatory updates blog provides professionals in the life sciences with timely and insightful information on the latest regulatory trends, guidelines, and compliance requirements. Covering topics from pharmaceutical manufacturing standards to medical device approvals, the blog aims to support readers in navigating complex regulatory landscapes, ensuring product safety, and accelerating time to market. Whether you're involved in quality assurance, regulatory affairs, or product development, this blog offers valuable resources to keep you informed and compliant.

Regulatory Updates

Select your

or

Pablo Palomar, Senior Toxicology Officer at QbD Group

Recent Posts

Nitrosamines Update EMA/409815/2020 Rev.22

The FDA releases revision of guidance regarding Control of Nitrosamine Impurities in Human Drugs

New Update of Appendix 1 of the Nitrosamines Guideline

Latest Update on Appendix 1 of the Nitrosamine Guidelines

Events calendar

June

24.06 - 26.06

CPHI China

26.06 - 27.06

PDA Advanced Therapy Medicinal Products Conference (Europe)

July

27.07 - 31.07

ADLM

August

29.08 - 01.09

ESC Congress

September

07.09 - 11.09

LSI Europe

17.09 - 17.09

Farmaforum

23.09 - 23.09

BioWin day

25.09 - 25.09

QbD Group x Gevers Roadshow: Liège

29.09 - 01.10

TOPRA annual Symposium

October

07.10 - 08.10

World Drug Safety Congress

07.10 - 10.10

RAPS US Convergence

16.10 - 16.10

Healixia Clinical Conference

19.10 - 20.10

Annual EU In Vitro Diagnostics Clinical & Regulatory Conference (Q1)

23.10 - 23.10

QbD Group x Gevers Roadshow: Liège

23.10 - 24.10

Team-PRRC Annual Summit

25.10 - 28.10

TCT 2025

28.10 - 30.10

CPHI Europe

November

17.11 - 20.11

Medica

December

11.12 - 11.12

Dutch Life Science conference